Fingerprint
Dive into the research topics of 'A nationwide prospective registry of bortezomib-based therapy in light chain (AL) amyloidosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A nationwide prospective registry of bortezomib-based therapy in light chain (AL) amyloidosis
on behalf of the AIFA’s Monitoring Registries Group
Research output: Contribution to journal › Article › peer-review